相关实验视频
Updated: Sep 17, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
499
TEVAR与B型大动脉解剖不复杂的最佳医学疗法相比:系统性审查和元分析
Matti Jubouri1, Abdelaziz O Surkhi2, Abdullah I Alsarayrah3
1Hull York Medical School, University of York, York, UK.
Annals of vascular surgery
|June 29, 2025
概括
胸内血管大动脉修复 (TEVAR) 显示,与单独的最佳医学疗法 (OMT) 相比,B型大动脉解剖无并发症 (unTBAD) 的生存率有所提高. 需要进行进一步的研究,以便为这组患者制定最终的指导方针.
科学领域:
- 心血管外科心血管外科
- 血管医学 血管医学
- 医疗成像医学成像
背景情况:
- 不复杂的B型大动脉剖析 (unTBAD) 管理是争论的.
- 最佳医疗疗 (OMT) 和胸内血管大动脉修复 (TEVAR) 是主要的治疗选择.
- 评估TEVAR对死亡率和并发症的影响至关重要.
研究的目的:
- 为了比较TEVAR加OMT与单独OMT对unTBAD的长期结果.
- 评估TEVAR对整体死亡率和特定并发症的影响.
- 分析非TBAD患者的存活率和大动脉重塑.
主要方法:
- 对UnTBAD的TEVAR和OMT进行比较的研究的元分析.
- 在PubMed,Ovid,Scopus和EMBASE上进行的搜索.
- 使用Jamovi进行的统计分析,遵循PRISMA指南.
主要成果:
- 分析包括了25650名患者 (4609名TEVAR,21041名OMT).
- 在30天死亡率上没有显著差异;TEVAR在1,2,3年后的生存率有所改善.
- TEVAR组的生存率:在基线时98%,1年后94%,2年后83.7%,3年后89.9%.
结论:
- TEVAR可能会改善非TBAD患者的存活率,尽管最终证据尚未得到.
- 在TEVAR后观察到改善的大动脉重塑.
- 随机试验和高风险特征的识别是指导方针的发展所需的.
相关概念视频
Aortic Regurgitation III: Medical Management
52
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
52
Aneurysm III: Interprofessional Care
29
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
29
Mitral Stenosis III: Medical Management
28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34

